Financhill
Back

LakeShore Biopharma Stock Predictions

LakeShore Biopharma Stock Forecast

  • Is LakeShore Biopharma Stock Undervalued?
    The current LakeShore Biopharma [LSB] share price is $2.69. The Score for LSB is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • LSB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will LakeShore Biopharma Stock Go Up Next Year?

Data Unavailable

LakeShore Biopharma Stock Rating

Data Unavailable

LakeShore Biopharma Stock Price History

Is LSB stock going to rise?

  • The current trend is moderately bearish and LSB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
China
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lakeshorebio.com

52-Week Data

52-Week High:
11.20
52-Week Low:
1.88

Prediction Charts

Market Cap:
51.33M
Price in USD:
2.69
Volume:
2.65K
Beta:
0.74

Technical Analysis

SMA50:
2.58
SMA100:
1.52
SMA200:
1.12
52-Wk Change:
-56.87%

Stock Predictions

  • Is LakeShore Biopharma stock public?
    Yes, LakeShore Biopharma is a publicly traded company.
  • What is the LakeShore Biopharma stock quote today?
    The LakeShore Biopharma stock price is 2.69 USD today.
  • How to buy LakeShore Biopharma stock online?
    You can buy LakeShore Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-6 2.23 2.17 2.36 2.15
Nov-7 2.01 2.30 2.35 1.98
Nov-8 2.23 2.00 2.34 1.91
Nov-11 2.05 2.42 3.23 2.00
Nov-12 2.30 3.16 3.20 2.27
Nov-13 2.91 3.10 3.16 2.91
Nov-14 3.15 2.59 3.44 2.55
Nov-15 2.70 2.60 2.76 2.50
Nov-18 2.73 2.43 2.79 2.43
Nov-19 2.49 2.49 2.63 2.36
Nov-20 2.46 2.62 2.62 2.41
Nov-21 2.63 2.57 2.94 2.25
Nov-22 2.57 2.62 2.70 2.40
Nov-25 2.62 2.69 2.69 2.55

LakeShore Biopharma Earnings

Data Unavailable

LakeShore Biopharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.21 per share.

* LakeShore Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.